tradmap

TRAX Earnings First Tracks Biotherapeutics, Inc.

Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Chart & overview → Latest filing

Quarterly results

Diluted EPS (quarterly)
-$1 -$1 $0 Q2 '25 Q2 '26
EPS
Net income (quarterly)
-$50M -$25M $0 Q1 '25 Q2 '25 Q1 '26 Q2 '26
Net income
Return on equity (quarterly)
-20% -10% 0% Q1 '25 Q2 '25 Q1 '26 Q2 '26
ROE

Reported EPS history

1–2 of 2
Q2 20262026-06-30-0.952026-08-1210-Q
Q2 20252025-06-30-1.47——

Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Informational only — not financial advice.